Michael Rulli

Leveling the Playing Field 2.0 Act

This bill addresses unfair trade practices by making various changes to U.S. antidumping and countervailing duty laws. Antidumping laws provide relief to U.S industries and workers that are materially injured or threatened with injury due to imports of like products sold in the U.S. market at less than fair value, while countervailing duty laws provide such relief from imports of products subsidized by a foreign government or public entity.

Specifically, the bill establishes a process for successive antidumping and countervailing duty investigations. Successive investigations may be concurrent (an ongoing investigation of the same product) or recently completed (not more than two years before the date of the initiation of the successive investigation). Further, the bill establishes a timeline for the Department of Commerce to issue determinations in successive investigations.

Among other provisions, the bill authorizes Commerce to

• apply countervailing duty law to subsidies provided by a foreign government or public entity to a company operating in a different country,

• use another method for calculating the cost of production in specific circumstances, and

• require importers to certify that the imported merchandise is not subject to an antidumping or countervailing duty order.

Additionally, the bill statutorily establishes procedures for Commerce to conduct circumvention inquiries, including by specifying the deadlines for preliminary and final determinations.

The bill also provides statutory authority for Commerce to investigate currency undervaluation as a countervailable subsidy.

Disengaging Entirely From the United Nations Debacle Act of 2025 or the DEFUND Act of 2025

This bill directs the President to terminate U.S. membership in the United Nations (U.N.) and all formally affiliated bodies. It also ends U.S. participation in all U.N. conventions and agreements.

Funds may be appropriated to facilitate U.S. withdrawal from the U.N. No funds may be made available for contributions or payments to any U.N. body.

The bill prohibits U.S. participation in any U.N. peacekeeping operation.

The bill also repeals diplomatic immunity for officers and employees of the U.N. and for officers and employees of foreign government missions to the U.N.

The bill repeals various acts related to the U.N., including the United Nations Participation Act of 1945, the United Nations Headquarters Agreement Act, and a joint resolution establishing U.S. membership in the World Health Organization.

The United States may not rejoin the U.N. or any formally affiliated body without the advice and consent of the Senate. Any agreement to rejoin the U.N. or a formally affiliated body must include the right of the United States to withdraw from the agreement.

Combating Illicit Xylazine Act

This bill regulates xylazine under the Controlled Substances Act (CSA).

Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.

Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.

The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.

The bill also exempts xylazine manufacturers from the CSA's physical security requirements.

Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.

Give Kids a Chance Act of 2025

This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.

Specifically, the bill

• modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met;

• permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement;

• renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and

• reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.

The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra, a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

United Nations Voting Accountability Act of 2025

This bill prohibits giving assistance, such as various types of economic support or military training, to countries that shared U.S. positions on less than 50% of the recorded votes in the most recent United Nations session.

A country may be exempted from this prohibition if the Department of State determines that the country will no longer oppose U.S. positions due to a fundamental change in the country's leadership and policies.

This bill bars the use of federal funds to carry out any functions, duties, or responsibilities of the U.S. Agency for International Development (USAID). The bill also (1) rescinds the unobligated balances of any funds made available to USAID prior to enactment, and (2) transfers any USAID assets or liabilities to the Department of State.

COVID-19 Vaccination Non-Discrimination Act

This bill prohibits making federal funds available to any facility that refuses to treat an individual based on the individual's COVID-19 vaccination status, including any funding under Medicare, Medicaid, or the Children's Health Insurance Program (CHIP).

Susan Muffley Act of 2025

This bill restores the full vested monthly benefits for eligible participants of certain pension plans that were sponsored by Delphi Corporation and terminated as a result of General Motors' bankruptcy in 2009.

The Pension Benefit Guaranty Corporation (PBGC) must recalculate and adjust each plan participant's monthly benefits payment. The PBGC must also apply the recalculation to previously-made monthly payments and make a lump-sum payment for any additional benefits based on the recalculation.

The bill establishes and provides appropriations to a fund for the payment of these benefits and specifies how the lump-sum payments are treated for tax purposes.

Smithsonian American Women’s History Museum Act

This bill authorizes the Smithsonian American Women's History Museum to be located on a particular site within the Reserve of the National Mall in Washington, DC.

Specifically, the bill designates the South Monument site as the location for the museum; however, the President may designate an alternative site within 180 days of the bill's enactment. (The site is the undeveloped land across the National Mall from the National Museum of African American History and Culture.) Administrative jurisdiction of the site must be transferred to the Smithsonian Institution.

The Board of Regents of the Smithsonian Institution must have the approval of specified federal entities (e.g., the Commission of Fine Arts) to plan, design, and construct a museum building. The bill (1) outlines the criteria for considering site and design proposals, and (2) requires the Smithsonian Institution to reimburse for costs resulting from the building approval process.

The bill directs the museum to be dedicated to preserving, researching, and presenting the history, achievements, and lived experiences of biological women in the United States. Under this bill, the museum may not identify, present, describe, or depict any biological male as a female.

In carrying out its duties, the museum's advisory council must (1) seek and utilize guidance from a broad array of knowledgeable and respected sources reflecting the diversity of the political viewpoints and authentic experiences held by women in the United States, and (2) seek guidance for the creation and substantial revision of exhibits and programs.

Voter Eligibility Verification Act of 2025

This bill requires the Department of Homeland Security to respond within 15 days of receiving a request from certain state officials for the immigration status of an individual on a list of potential voters.

This concurrent resolution declares that Congress should not impose any new performance fee, tax, royalty, or other charge relating to the public performance of sound recordings on a local radio station for broadcasting sound recordings over the air, or on any business for such public performance of sound recordings.

Protecting Privacy in Purchases Act

This bill prohibits payment card networks from using merchant codes that distinguish firearms retailers from general-merchandise retailers or sporting-goods retailers.

The Department of Justice must enforce this bill and report annually on the resulting investigations and cases.

Alpha-gal Allergen Inclusion Act

This bill expands the definition of major food allergen to include galactose-alpha-1,3-galactose (commonly known as alpha-gal). Under current law, food labels generally must identify each major food allergen found in labeled food products.

(Certain tick bites cause an allergic condition known as alpha-gal syndrome that can result in an allergy to the alpha-gal molecule, which is found in red meat and other products made from mammals.)

No Social Security for Illegal Aliens Act of 2025

This bill excludes wages and self-employment income earned by non-U.S. nationals (aliens under federal law) who are not authorized to work in the United States from consideration for purposes of Social Security eligibility and benefits.

This exclusion applies with respect to all such wages and self-employment income earned both before and after the bill’s enactment. However, any change to the amount of an individual’s Social Security benefits as a result of these provisions may only apply to benefits for months after the bill’s enactment.

Protecting Access for Hunters and Anglers Act of 2025

This bill bars the Fish and Wildlife Service (FWS), the Bureau of Land Management (BLM), and the Forest Service from prohibiting or regulating the use of lead ammunition or tackle on federal land or water. The bill makes exceptions for specified existing regulations and where the FWS, the BLM, or the Forest Service determines that a decline in wildlife population at the specific unit of federal land or water is primarily caused by the use of lead in ammunition or tackle, based on the field data from such unit, and the state approves the regulations.

East Palestine Health Impact Monitoring Act of 2025

This bill requires the Department of Health and Human Services to provide a grant to a consortium of institutions of higher education to conduct a long-term study on any human health effects from the train derailment (and subsequent venting and burning of chemicals) in East Palestine, Ohio, on February 3, 2023.

This joint resolution nullifies the Environmental Protection Agency rule titled Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020 and published on October 11, 2024. The rule establishes an emission reduction and reclamation program for the management of hydrofluorocarbons, which are greenhouse gases. The rule also establishes alternative Resource Conservation and Recovery Act standards for certain ignitable spent refrigerants being recycled for reuse.

This joint resolution nullifies the rule titled Energy Conservation Program: Energy Conservation Standards for Consumer Gas-fired Instantaneous Water Heaters and submitted by the Department of Energy (DOE) on December 26, 2024. Under the rule, DOE adopted amended energy conservation standards for gas-fired instantaneous water heaters to achieve the maximum improvement in energy efficiency that DOE determined was technologically feasible and economically justified.